Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» July 2010
July 2010
4-Star Stocks Poised to Pop: Eli Lilly
4-Star Stocks Poised to Pop: Eli Lilly
Motley Fool
Eli Lilly
Who is Killing the Pharmaceutical Sales Position?
Who is Killing the Pharmaceutical Sales Position?
Pharmareform
drug reps
Celgene Beats and Raises Guidance
Celgene Beats and Raises Guidance
TheStreet.com
Celgene
earnings
FTC: ‘Tide May Be Turning’ On Pay-To-Delay Deals
FTC: ‘Tide May Be Turning’ On Pay-To-Delay Deals
Pharmalot
FTC
pay-for-delay
Apotex
Watson Pharmaceuticals
Solvay
Abbott Laboratories
generics
Sanofi Board Said to Support Genzyme Bid of Up to $18.7 Billion
Sanofi Board Said to Support Genzyme Bid of Up to $18.7 Billion
Bloomberg
Genzyme
M&A
Sanofi
Even After Patent Cliff, Pfizer Is Undervalued
Even After Patent Cliff, Pfizer Is Undervalued
Yahoo/Morningstar
Pfizer
patents
Bayer Cuts Full-Year Forecasts at Two of Three Units as Profit Declines
Bayer Cuts Full-Year Forecasts at Two of Three Units as Profit Declines
Bloomberg
Bayer
earnings
Sanofi Second-Quarter Profit Climbs 7.6% on Demand for Diabetes Medicines
Sanofi Second-Quarter Profit Climbs 7.6% on Demand for Diabetes Medicines
Bloomberg
earnings
Sanofi
Alexza Pharmaceuticals: Warming Up or Cooling Off?
Alexza Pharmaceuticals: Warming Up or Cooling Off?
Motley Fool
Alexza
What Investors Think About Allos Therapeutics
What Investors Think About Allos Therapeutics
Motley Fool
Allos
investors
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »